A federal appellate court has handed down the first appellate-level decision addressing the merits of drug manufacturers’ challenges to the Inflation Reduction Act of 2022's (IRA) Medicare Drug ...

“While we support affordable health care, the price controls that we are challenging would reduce access to new medicines that Americans are counting on, and would set a devastating precedent for all ...

With large pharma companies now confronting a two-pronged assault on U.S. drug prices, Novo has received a lift on its petition for the Supreme Court hear its challenge to the Medicare price ...

Following failed funding bills and continued government shutdown, Oklahoma Senator James Lankford speaks to News On 6 about negotiation challenges and the impact on federal employees. The Senate met ...

Explore the cutting edge of negotiation education in this dynamic webinar featuring distinguished faculty from the Kellogg School of Management. Known for pioneering a team-based, experiential ...